Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$188,717,132
+$106,776,485 QoQ
Shares Held
3,601,472
+55.4% QoQ
Ownership
2.15%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#12
of 423 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Derivatives in ALKS
reported options exposure · as of Jun 30, 2026CallValue
$18,340,000
CallShares
350,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Holocene Advisors, LP holds $298,952,947 across 6 Drug Manufacturers - Specialty & Generic names. ALKS ranks #1 (63.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
This page
|
3,601,472 | $188,717,132 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
546,961 | $60,679,853 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
1,694,717 | $41,706,985 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
166,867 | $5,653,453 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
38,962 | $1,350,812 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,559 | $844,712 |
All Filings in ALKS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,340,000 | 350,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $188,717,132 | 3,601,472 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $81,940,647 | 2,317,326 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $74,070,900 | 2,469,030 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $81,646,302 | 2,853,768 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $71,805,358 | 2,174,602 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,417,290 | 257,903 | Shares | Sole | 2025-02-14 | |
| 2023-06-30 | $39,217,428 | 1,252,953 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $77,864,980 | 2,762,149 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $69,024,380 | 2,641,576 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $54,421,269 | 2,437,137 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $58,254,553 | 1,955,507 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $67,709,416 | 2,573,524 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $68,961,061 | 2,964,792 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $78,795,459 | 2,554,976 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $54,115,566 | 2,206,997 | Shares | Sole | 2021-08-16 | |
| 2021-06-30 | $12,014,800 | 490,000 | Call | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||